Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anastrozole plus growth hormone for boys with Prader-Willi syndrome and advanced bone age
ChiCTR1900027464Phase 4Not yet recruiting
- Sponsor
- Children's Hospital, Zhejiang University School of Medicine
- Start
- Dec 2019
- Modality
- Recombinant Proteins and Enzymes, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of anastrozole and somatropin in Prader-Willi syndrome (PWS) (2 arms), sponsored by Children's Hospital, Zhejiang University School of Medicine. Primary endpoints: Height, Weight and 14 more. Planned start Dec 2019; status: not yet recruiting.
02
Drugs
anastrozolesomatropin
03
Conditions
Prader-Willi syndrome (PWS)
Beyond the preview
Go deeper on ChiCTR1900027464.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900027464.